Ocular Hypertension study: Nanodropper vs Regular dropper
Official title Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
ClinicalTrials.gov ID: NCT05844384
What this study is testing
- What it's testing
- This study checks if a special dropper that delivers tiny amounts of medicine is just as safe and effective as regular eye drops.
- Who it's for
- People with high eye pressure or a type of glaucoma called primary open-angle glaucoma.
- What's involved
- Participants will use both the new dropper and standard drops to see how their eyes respond to each.
- Time commitment
- The study involves switching between the two types of drops over time, but the total duration is not specified.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- POAG/OHTN patients above the age of 18 years.
- On a maximum of 2 IOP lowering medications.
- Stable disease without progression in IOP, optic disc cupping, RNFL changes, and visual field changes within the previous 1 year.
You likely can't join if
- Glaucoma not of the POAG or OHTN variety or other retinal diseases.
- Progression of disease within the preceding 1 year (IOP elevation, optic disc cupping, visual field changes).
- Using more than 2 IOP-lowering medications.
- IOP-lowering surgical interventions or lasers except for SLT. SLT may have been completed 6+ months prior to study start date.
The study team makes the final eligibility decision.
Where it is enrolling
- Lackland Air Force Base, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Lackland Air Force Base, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.